IS ANTI-FACTOR XA ACTIVITY IMPORTANT

被引:0
|
作者
HEMKER, HC [1 ]
机构
[1] STATE UNIV LIMBURG,CTR BIOMED,DEPT BIOCHEM,6200 MD MAASTRICHT,NETHERLANDS
来源
关键词
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
引用
下载
收藏
页码:268 / 268
页数:1
相关论文
共 50 条
  • [21] Anti-factor Xa Activity of Enoxaparin for Thromboprophylaxis in Nonsurgical Patients Is Dependent on Body Mass
    Jimenez, David
    Diaz, Gema
    Iglesias, Ana
    Cesar, Jesus
    Garcia-Avello, Angel
    Marti, David
    Escobar, Carlos
    Vidal, Rafael
    Sueiro, Antonio
    ARCHIVOS DE BRONCONEUMOLOGIA, 2008, 44 (12): : 660 - 663
  • [22] THE INHIBITION OF THE GENERATION OF THROMBIN AND THE ANTITHROMBOTIC EFFECT OF A PENTASACCHARIDE WITH SOLE ANTI-FACTOR XA ACTIVITY
    WALENGA, JM
    BARA, L
    PETITOU, M
    SAMAMA, M
    FAREED, J
    CHOAY, J
    THROMBOSIS RESEARCH, 1988, 51 (01) : 23 - 33
  • [23] Distribution of Anti-Factor Xa Activity Value, Prothrombin Time, and Activated Partial Thromboplastin Time in Patients Treated With Factor Xa Inhibitors
    Ono, Ryohei
    Fukushima, Kenichi
    Takahashi, Hidehisa
    Hori, Yasuhiko
    Kobayashi, Yoshio
    CIRCULATION, 2022, 146
  • [24] Design and Implementation of an Anti-Factor Xa Heparin Monitoring Protocol
    Williams-Norwood, Tanya
    Caswell, Megan
    Milner, Barbara
    Vescera, Joseph C.
    Prymicz, Kelly
    Ciszak, Amy G.
    Ingle, Carol
    Lacey, Christopher
    Stavrou, Evi X.
    AACN ADVANCED CRITICAL CARE, 2020, 31 (02) : 129 - 137
  • [25] CORRELATION OF ANTI-FACTOR XA ACTIVITY VALUE, PROTHROMBIN TIME, AND ACTIVATED PARTIAL THROMBOPLASTIN TIME IN PATIENTS TREATED WITH FACTOR XA INHIBITORS
    Ono, Ryohei
    Fukushima, Kenichi
    Takahashi, Hidehisa
    Hori, Yasuhiko
    Kobayashi, Yoshio
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 2109 - 2109
  • [26] Utilization of anti-factor Xa levels to guide reversal of oral factor Xa inhibitors in the emergency department
    Zepeski, Anne E.
    Faine, Brett A.
    Merrill, Anna E.
    Sutamtewagul, Grerk
    Bhagavathi, Sharathkumar
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2022, 79 (01) : E20 - E26
  • [27] Synthesis and biological activity of a new anti-factor Xa pentasaccharide with a C-interglycosidic bond
    Helmboldt, A
    Petitou, M
    Mallet, JM
    Herault, JP
    Lormeau, JC
    Driguez, PA
    Herbert, JM
    Sinay, P
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (12) : 1507 - 1510
  • [28] The effect of freezing and thawing of samples for anti-factor Xa testing for the determination of enoxaparin activity.
    Louw, Susan
    Gounden, Reenelle
    Vaughan, Jenifer
    Ntabeni, Lumka
    Mayne, Anthony
    Mayne, Elizabeth S.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2021, 43 (03) : E138 - E140
  • [29] Anti-factor Xa activity of enoxaparin in pregnant women with pregnancy loss associated with antiphospholipid antibodies
    Grand, B
    Ventura, A
    Riveros, D
    THROMBOSIS RESEARCH, 2005, 115 : 120 - 120
  • [30] Measurement of Anti-Factor Xa Activity in Patients on Apixaban for Non-Valvular Atrial Fibrillation
    Osanai, Hiroyuki
    Ajioka, Masayoshi
    Masutomi, Tomohiro
    Kuwayama, Tasuku
    Ishihama, Sota
    Sakamato, Yusuke
    Otaka, Naoya
    Sakaguchi, Teruhiro
    Inoue, Yosuke
    Kanbara, Takahiro
    Nakashima, Yoshihito
    Asano, Hiroshi
    Sakai, Kazuyoshi
    CIRCULATION JOURNAL, 2015, 79 (12) : 2584 - 2590